The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

The stock of Vertex Pharmaceuticals Incorporated VRTX has declined around 1.2% in the past three months, losing almost $3 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vertex Pharma has said it will use a priority review voucher (PRV) to speed up the FDA review of its new once-daily triple therapy for cystic fibrosis, which has just hit all its objectives in a ...

Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A conference call will be held that same day at 9:00 A.M. ET to review the Company's financial results and discuss recent events. HOUSTON, July 17, 2024--Vertex Energy, Inc. (NASDAQ:VTNR ...

In the meantime current gene therapies remain expensive and challenging to scale up because each patient’s batch of cells has ...

Vertex Pharmaceuticals is different from Novo Nordisk in several ways. The two companies could compete against each other in the future. Vertex is a better pick than Novo right now for one key reason.

(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced the launch of Vertex for Salesforce Revenue Cloud. This integration brings together Vertex’s ...

Vertex Energy, Inc. (NASDAQ:VTNR) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, today announced that Doug Haugh is stepping down from his role ...

Haystack is an easy open-source framework for building RAG pipelines and LLM-powered applications, and the foundation for a ...